BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27611099)

  • 1. Characterization of forced degradation products of clozapine by LC-DAD/ESI-Q-TOF.
    Skibiński R; Trawiński J; Komsta Ł; Bajda K
    J Pharm Biomed Anal; 2016 Nov; 131():272-280. PubMed ID: 27611099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of forced degradation products of toloxatone by LC-ESI-MS/MS.
    Skibiński R; Trawiński J; Komsta Ł; Murzec D
    Saudi Pharm J; 2018 May; 26(4):467-480. PubMed ID: 29844717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of photodegradation product of amisulpride by ultra-high-pressure liquid chromatography-DAD/ESI-quadrupole time-of-flight-mass spectrometry.
    Skibiński R
    J Pharm Biomed Anal; 2011 Dec; 56(5):904-10. PubMed ID: 21852060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry - study of degradation kinetic.
    Lecoeur M; Vérones V; Vaccher C; Bonte JP; Lebegue N; Goossens JF
    Eur J Pharm Sci; 2012 Apr; 45(5):559-69. PubMed ID: 22207039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
    Gu X; Chen Y; Lou Y; Zheng J
    J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
    Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of four new photodegradation products of hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF studies.
    Saini B; Bansal G
    J Pharm Biomed Anal; 2013 Oct; 84():224-31. PubMed ID: 23850938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of paliperidone photodegradation products by LC-Q-TOF multistage mass spectrometry.
    Skibiński R; Komsta Ł; Inglot T
    Biomed Chromatogr; 2016 Jun; 30(6):894-901. PubMed ID: 26400838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.
    Wróblewski K; Szultka-Młyńska M; Janiszewska D; Petruczynik A; Buszewski B
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation kinetics study of cabozantinib by a novel stability-indicating LC method and identification of its major degradation products by LC/TOF-MS and LC-MS/MS.
    Wu C; Xu X; Feng C; Shi Y; Liu W; Zhu X; Zhang J
    J Pharm Biomed Anal; 2014 Sep; 98():356-63. PubMed ID: 24992215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.